Purposeful innovation. Empowered care.
Philips at EuroPCR 2022
17-20 May, Palais des Congrès, Paris.
To empower better heart care, Philips uniquely innovates and integrates imaging, devices, software, informatics and services.
We look forward to connecting with you online or at our booth F22.
Join our symposium
How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast.
May 17 | 17:15-18:15 | Studio A
Moderator : Nieves Gonzalo
Anchorperson: Jean Fajadet
Speakers: Javier Escaned, Billal Patel, Dariusz Dudek, Jeffrey Moses
Training village
Our solutions support interventionalists in minimizing the contrast-load for the patient and physicians, and in performing interventional procedures with clarity and confidence, improving cardiac care experiences for staff and patients. Join our training village at EuroPCR and learn more.
Discover our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check availability in your country.
IntraSight Mobile
IntraSight Mobile is an easy-to-use, small footprint, IVUS imaging and physiology system, designed for coronary and peripheral vascular procedures, operable directly from the sterile field.
Ultra low contrast PCI
Most cardiac patients fall under high-risk category for acute kidney injury (AKI) 1
EchoNavigator Release 4.0
Helps to strengthen and streamline communication and collaboration, delivers automated anatomical insights, enables simultaneous visualization of devices, soft tissue and 3D imaging, and supports an advanced fusion imaging workflow.
Azurion R2.1
Philips Azurion is the next generation image-guided therapy platform that allows you to easily and confidently perform procedures with a unique user experience, helping you optimise your lab performance and provide superior care.
Hemo with IntelliVue X3
Philips introduces the Interventional Hemodynamic system (Hemo system) which brings advanced hemodynamic measurements to the cath lab. Integrated with the market leading IntelliVue X3 patient monitor, this unique combination enables continuous patient monitoring throughout the cath lab.
Continuous monitoring
The IntelliVue X3 portable monitor stays connected to the patient for consistent physiological monitoring and timely detection of potential adverse events during every stage of their journey.
Sign up to receive news and updates on our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.
Enter our cardiology virtual space
Explore all the latest Philips cardiology innovations including our informatics solutions which bring meaningful data together across the cardiovascular care continuum.
Clinical and workflow solutions
iFR Co-registration
IVUS guidance
Coronary diagnostic for Complex PCI
IntelliSpace Cardiovascular
@PhilipsLiveFrom
Our PR Contacts
Joost Maltha Joost.maltha@philips.com Philips Global Press Office Tel: +31 6 10 55 8116
References:
1 Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7): 1393-1399. doi:10.1016/j.jacc.2004.06.068.
